Pharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome

'0.1':28,70,108 'cannabi':23,65,103 'cannabidiol':20,62,100 'contain':19,61,99 'deriv':21,63,101 'dosag':16,58,96 'dravet':38,78,118 'drug':12,54,92 'finish':15,57,95 'formul':17,59,97 'gestaut':43,83,123 'infus':86 'lennox':42,82,122 'lennox-gestaut':41,81,121 'medicin':85 'natur':9,51,89 'percent':29,71,109 'pharmaceut':1,45 'prepar':4,46 'product':13,55,93 'residu':30,72,110 'substanc':6,48 'syndrom':39,44,79,84,119,124 'tetrahydrocannabinol':31,73,111 'treatment':36,76,116 'use':33,113 'veterinari':3

EPIDYOLEX

Owner

Goods & Services